Amanote Research
Register
Sign In
Developing a Novel Inhaled Therapeutic for the Treatment of Bronchiolitis Obliterans Syndrome
doi 10.32907/ro-109-142145
Full Text
Open PDF
Abstract
Available in
full text
Date
August 28, 2019
Authors
Unknown
Publisher
Research Outreach
Related search
Therapeutic Options for Bronchiolitis Obliterans Syndrome After Lung Transplantation
Eurasian Journal of Pulmonology
Prevention of the Second Stage of Epithelial Loss Is a Potential Novel Treatment for Bronchiolitis Obliterans
Journal of Thoracic and Cardiovascular Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
Circulating Fibrocytes Correlate With Bronchiolitis Obliterans Syndrome Development After Lung Transplantation: A Novel Clinical Biomarker
Annals of Thoracic Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
Bronchiolitis Obliterans Syndrome and Additional Costs of Lung Transplantation
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Parametric Response Mapping as a Diagnostic Indicator of Bronchiolitis Obliterans Syndrome
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Orphan Designation: Recombinant Human Club Cell 10 KDa Protein, Treatment of Bronchiolitis Obliterans Syndrome
Case Medical Research
S53 Alarmins in Bronchiolitis Obliterans Syndrome After Lung Transplantation
Thorax
Pulmonary
Respiratory Medicine
Bronchiolitis Obliterans Syndrome Leads to a Functional Deterioration of the Acinus Post Lung Transplant
Thorax
Pulmonary
Respiratory Medicine
Lung Clearance Index in Detection of Post-Transplant Bronchiolitis Obliterans Syndrome
ERJ Open Research
Pulmonary
Respiratory Medicine